Rockwell Medical, Inc.RMTINASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | -89.29% |
| Q4 2023 | -65.99% |
| Q3 2023 | 195.81% |
| Q2 2023 | -39.93% |
| Q1 2023 | 78.21% |
| Q4 2022 | -66.74% |
| Q3 2022 | -49.35% |
| Q2 2022 | -40.91% |
| Q1 2022 | 12.73% |
| Q4 2021 | 13.84% |
| Q3 2021 | -49.46% |
| Q2 2021 | 33.55% |
| Q1 2021 | -5.24% |
| Q4 2020 | 9.40% |
| Q3 2020 | 7.98% |
| Q2 2020 | -11.31% |
| Q1 2020 | -6.85% |
| Q4 2019 | 32.63% |
| Q3 2019 | -50.15% |
| Q2 2019 | 494.90% |
| Q1 2019 | -81.64% |
| Q4 2018 | 235.17% |
| Q3 2018 | -48.16% |
| Q2 2018 | -6.45% |
| Q1 2018 | -21.63% |
| Q4 2017 | 62.99% |
| Q3 2017 | -22.13% |
| Q2 2017 | 37.92% |
| Q1 2017 | 1.18% |
| Q4 2016 | -4.84% |
| Q3 2016 | -38.84% |
| Q2 2016 | 56.97% |
| Q1 2016 | -35.24% |
| Q4 2015 | 62.81% |